A topline review of 3 more of the top 6 studies of 2017 in afib includes the death of digoxin, go and no-go foods, and afib and ESRD.
Atrial Fibrillation More Prevalent in US Than Previously Estimated: Daily Dose
Your daily dose of the clinical news you may have missed.
Women and Heart Disease: Incidence, Prevalence, Progress, and the Future
Female CV mortality lags behind male mortality; lifetime risk assessment, not 10-year risk, is a better estimation tool for women
Atrial Fibrillation May be More Common in Younger Adults than Previously Thought: Daily Dose
The Great Beta-Blocker Debate: The Pros and Cons
Newly diagnosed hypertension in a patient whose blood pressure is 152/94 mm Hg. What agents will you consider for this patient? Beta-blockers? Think again.
Concomitant SSRI and DOAC Use Increases Risk of Major Bleeding, Including ICH: New Findings
Overall, a 33% increased risk of major bleeding was seen, with risk highest during the first 30 days of concomitant use and persistent, but lower, after 6 months.
Apixaban and Aspirin Equal in Preventing Stroke Recurrence in Cardiopathy: Daily Dose